Patent Yard Sign in
Expired Canadian patentCanada

Method of treating acute coronary syndromes

CA 2530460 C · Owner: Edelman, Elazer R. · Inventors: Richter, Yoram; Golomb, Gershon; Danenberg, Haim D.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to methods and compositions designed for the treatment or management of acute coronary syndromes particularly, unstable , angina and acute myocardial infarction. The methods of the invention comprise the administration of an effective amount of a formulation containing one or more therapeutic agents which specifically decreases or inhibits the activity of phagocytic cells and/or eliminates or diminishes the amount of phagocytic cells including, but not limited to, macrophages and monocytes. The formulations are specifically targeted to phagocytic cells. The invention also provides pharmaceutical compositions of formulations containing one or more …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 24, 2004 and granted August 14, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 24, 2024.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 24, 2026.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 24, 2004
GrantedAugust 14, 2012
Term endedJune 24, 2024
Patent numberCA 2530460 C
Classification (IPC)A61K9/12 +1 more

Timeline

Timeline From CIPO dates

2005200720092011201320152017201920212023Application filedJune 24, 2004Patent grantedAug 14, 2012Term endedJune 24, 2024

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.